OBJECTIVES: Although biofeedback therapy is effective in the short-term management of dyssynergic defecation, its long-term efficacy is unknown. Our aim was to compare the 1-year outcome of biofeedback (manometric-assisted pelvic relaxation and simulated defecation training) with standard therapy (diet, exercise, laxatives) in patients who completed 3 months of either therapy. METHODS:Stool diaries, visual analog scales (VASs), colonic transit, anorectal manometry, and balloon expulsion time were assessed at baseline, and at 1 year after each treatment. All subjects were seen at 3-month intervals and received reinforcement. Primary outcome measure (intention-to-treat analysis) was a change in the number of complete spontaneous bowel movements (CSBMs) per week. Secondary outcome measures included bowel symptoms, changes in dyssynergia, and anorectal function. RESULTS: Of 44 eligible patients with dyssynergic defecation, 26 agreed to participate in the long-term study. All 13 subjects who received biofeedback, and 7 of 13 who receivedstandard therapy, completed 1 year; 6 failed standard therapy. The number of CSBMs per week increased significantly (P<0.001) in the biofeedback group but not in the standard group. Dyssynergia pattern normalized (P<0.001), balloon expulsion time improved (P=0.0009), defecation index increased (P<0.001), and colonic transit time normalized (P=0.01) only in the biofeedback group. CONCLUSIONS:Biofeedback therapy provided sustained improvement of bowel symptoms and anorectal function in constipated subjects with dyssynergic defecation, whereas standard therapy was largely ineffective.
RCT Entities:
OBJECTIVES: Although biofeedback therapy is effective in the short-term management of dyssynergic defecation, its long-term efficacy is unknown. Our aim was to compare the 1-year outcome of biofeedback (manometric-assisted pelvic relaxation and simulated defecation training) with standard therapy (diet, exercise, laxatives) in patients who completed 3 months of either therapy. METHODS: Stool diaries, visual analog scales (VASs), colonic transit, anorectal manometry, and balloon expulsion time were assessed at baseline, and at 1 year after each treatment. All subjects were seen at 3-month intervals and received reinforcement. Primary outcome measure (intention-to-treat analysis) was a change in the number of complete spontaneous bowel movements (CSBMs) per week. Secondary outcome measures included bowel symptoms, changes in dyssynergia, and anorectal function. RESULTS: Of 44 eligible patients with dyssynergic defecation, 26 agreed to participate in the long-term study. All 13 subjects who received biofeedback, and 7 of 13 who received standard therapy, completed 1 year; 6 failed standard therapy. The number of CSBMs per week increased significantly (P<0.001) in the biofeedback group but not in the standard group. Dyssynergia pattern normalized (P<0.001), balloon expulsion time improved (P=0.0009), defecation index increased (P<0.001), and colonic transit time normalized (P=0.01) only in the biofeedback group. CONCLUSIONS: Biofeedback therapy provided sustained improvement of bowel symptoms and anorectal function in constipated subjects with dyssynergic defecation, whereas standard therapy was largely ineffective.
Authors: Adil E Bharucha; Andrew J Croak; John B Gebhart; Lawrence J Berglund; Barbara M Seide; Alan R Zinsmeister; Kai-Nan An Journal: Am J Physiol Gastrointest Liver Physiol Date: 2006-02-02 Impact factor: 4.052
Authors: S M Patel; W B Stason; A Legedza; S M Ock; T J Kaptchuk; L Conboy; K Canenguez; J K Park; E Kelly; E Jacobson; C E Kerr; A J Lembo Journal: Neurogastroenterol Motil Date: 2005-06 Impact factor: 3.598
Authors: Giuseppe Chiarioni; William E Whitehead; Vincenzo Pezza; Antonio Morelli; Gabrio Bassotti Journal: Gastroenterology Date: 2006-03 Impact factor: 22.682
Authors: Satish S C Rao; Kara Seaton; Megan J Miller; Konrad Schulze; C Kice Brown; Jessica Paulson; Bridget Zimmerman Journal: J Psychosom Res Date: 2007-08-01 Impact factor: 3.006
Authors: S S C Rao; M A Benninga; A E Bharucha; G Chiarioni; C Di Lorenzo; W E Whitehead Journal: Neurogastroenterol Motil Date: 2015-04-01 Impact factor: 3.598
Authors: Subhankar Chakraborty; Kelly Feuerhak; Anjani Muthyala; William S Harmsen; Kent R Bailey; Adil E Bharucha Journal: Clin Gastroenterol Hepatol Date: 2018-08-18 Impact factor: 11.382